CD44 keeps tumor killers polarized

Thorsten R Mempel1, Francesco Marangoni

  • 1Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. tmempel@mgh.harvard.edu

Immunity
|December 23, 2008
PubMed

Related Concept Videos